Mary ElizabethStrekMary Elizabeth Strek41.78927490000000-87.601250000000002563Strek, Mary ElizabethDirector, Respiratory Clinical Research Program
Director, Pulmonary Medicine Service
Co-director, ILD Program
Associate Director, Adult CF CenterProfessorplugins:FeaturedPresentationsFeatured Presentationsplugins:FeaturedVideosFeatured Videosplugins:TwitterTwitterprns:awardConferredByaward conferred byprns:coAuthorOfcoauthor ofprns:emailEncryptedemail addressprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipvivo:awardOrHonorawards and honorsAward or Honor ReceiptDepartmentvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:overviewoverviewvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 1003603Authorship 101561127903693Strek ME, Oldham JM, Adegunsoye A, Vij RThe European respiratory journalA call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria. Eur Respir J. 2016 12; 48(6):1813-1814.Eur Respir J2016-12-01T00:00:002016A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria.27594777Witt LJ, Curran JJ, Strek MEClinical pulmonary medicineThe Diagnosis and Treatment of Antisynthetase Syndrome. Clin Pulm Med. 2016 Sep; 23(5):218-226.Clin Pulm Med2016-09-01T00:00:002016The Diagnosis and Treatment of Antisynthetase Syndrome.Authorship 1021931028350485Chung JH, Montner SM, Adegunsoye A, Lee C, Oldham JM, Husain AN, MacMahon H, Noth I, Vij R, Strek MEAJR. American journal of roentgenologyCT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features. AJR Am J Roentgenol. 2017 Jun; 208(6):1229-1236.AJR Am J Roentgenol2017-03-28T00:00:002017CT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features.Authorship 1026032028398598O'Donnell PH, Wadhwa N, Danahey K, Borden BA, Lee SM, Hall JP, Klammer C, Hussain S, Siegler M, Sorrentino MJ, Davis AM, Sacro YA, Nanda R, Polonsky TS, Koyner JL, Burnet DL, Lipstreuer K, Rubin DT, Mulcahy C, Strek ME, Harper W, Cifu AS, Polite B, Patrick-Miller L, Yeo KT, Leung E, Volchenboum SL, Altman RB, Olopade OI, Stadler WM, Meltzer DO, Ratain MJClinical pharmacology and therapeuticsPharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther. 2017 Nov; 102(5):859-869.Clin Pharmacol Ther2017-06-15T00:00:002017Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.Authorship 1042041428488693Hrusch CL, Manns ST, Bryazka D, Casaos J, Bonham CA, Jaffery MR, Blaine KM, Mills KAM, Verhoef PA, Adegunsoye AO, Williams JW, Tjota MY, Moore TV, Strek ME, Noth I, Sperling AIMucosal immunologyICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s. Mucosal Immunol. 2018 01; 11(1):61-70.Mucosal Immunol2017-05-10T00:00:002017ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s.D001327Disorders1332410.830421Autoimmune DiseasesAuthorship 1059181128467213Adegunsoye A, Oldham JM, Valenzi E, Lee C, Witt LJ, Chen L, Montner S, Chung JH, Noth I, Vij R, Strek ME, Husain ANArchives of pathology & laboratory medicineInterstitial Pneumonia With Autoimmune Features: Value of Histopathology. Arch Pathol Lab Med. 2017 Jul; 141(7):960-969.Arch Pathol Lab Med2017-05-03T00:00:002017Interstitial Pneumonia With Autoimmune Features: Value of Histopathology.Authorship 106570828687910Chung JH, Montner SM, Adegunsoye A, Oldham JM, Husain AN, Vij R, Noth I, Strek MEEuropean radiologyCT findings associated with survival in chronic hypersensitivity pneumonitis. Eur Radiol. 2017 Dec; 27(12):5127-5135.Eur Radiol2017-07-07T00:00:002017CT findings associated with survival in chronic hypersensitivity pneumonitis.D003240Disorders33670.923984Connective Tissue DiseasesReneaJablonskiRenea Jablonski41.7886000000000087.598699999999993713Jablonski, ReneaAssistant Professor29724923Adegunsoye A, Oldham JM, Bellam SK, Chung JH, Chung PA, Biblowitz KM, Montner S, Lee C, Hsu S, Husain AN, Vij R, Mutlu G, Noth I, Churpek MM, Strek METhe European respiratory journalAfrican-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis. Eur Respir J. 2018 06; 51(6).Eur Respir J2018-06-14T00:00:002018African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis.Authorship 10925415Authorship 11287510Authorship 11370417Authorship 1113163Authorship 1148389Authorship 11606511Authorship 11381814Authorship 11826710Authorship 1185671Authorship 11953617Authorship 11455710Authorship 1209584Authorship 1208882Authorship 120039628964798Adegunsoye A, Oldham JM, Chung JH, Montner SM, Lee C, Witt LJ, Stahlbaum D, Bermea RS, Chen LW, Hsu S, Husain AN, Noth I, Vij R, Strek ME, Churpek MChestPhenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort. Chest. 2018 02; 153(2):349-360.Chest2017-09-28T00:00:002017Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort.29422061Oldham JM, Witt LJ, Adegunsoye A, Chung JH, Lee C, Hsu S, Chen LW, Husain A, Montner S, Vij R, Strek ME, Noth IBMC pulmonary medicineN-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia. BMC Pulm Med. 2018 Feb 08; 18(1):30.BMC Pulm Med2018-02-08T00:00:002018N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia.28889888Chen LW, McShane PJ, Karkowsky W, Gray SE, Adegunsoye A, Stock W, Artz A, White SR, Montner SM, Strek MEChestDe Novo Development of Bronchiectasis in Patients With Hematologic Malignancy. Chest. 2017 09; 152(3):683-685.Chest2017-09-01T00:00:002017De Novo Development of Bronchiectasis in Patients With Hematologic Malignancy.28797493Muldoon EG, Strek ME, Patterson KCClinics in chest medicineAllergic and Noninvasive Infectious Pulmonary Aspergillosis Syndromes. Clin Chest Med. 2017 09; 38(3):521-534.Clin Chest Med2017-06-12T00:00:002017Allergic and Noninvasive Infectious Pulmonary Aspergillosis Syndromes.29490147Oldham JM, Adegunsoye A, Khera S, Lafond E, Noth I, Strek ME, Kadoch M, Chung JHAnnals of the American Thoracic SocietyUnderreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography. Ann Am Thorac Soc. 2018 06; 15(6):764-766.Ann Am Thorac Soc2018-06-01T00:00:002018Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography.29547052Chung JH, Oldham JM, Montner SM, Vij R, Adegunsoye A, Husain AN, Noth I, Lynch DA, Strek MEAJR. American journal of roentgenologyCT-Pathologic Correlation of Major Types of Pulmonary Fibrosis: Insights for Revisions to Current Guidelines. AJR Am J Roentgenol. 2018 May; 210(5):1034-1041.AJR Am J Roentgenol2018-03-16T00:00:002018CT-Pathologic Correlation of Major Types of Pulmonary Fibrosis: Insights for Revisions to Current Guidelines.29140119Chung JH, Cox CW, Montner SM, Adegunsoye A, Oldham JM, Husain AN, Vij R, Noth I, Lynch DA, Strek MEAJR. American journal of roentgenologyCT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis. AJR Am J Roentgenol. 2018 Feb; 210(2):307-313.AJR Am J Roentgenol2017-11-15T00:00:002017CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.30216085Adegunsoye A, Oldham JM, Bonham C, Hrusch C, Nolan P, Klejch W, Bellam S, Mehta U, Thakrar K, Pugashetti JV, Husain AN, Montner SM, Straus CM, Vij R, Sperling AI, Noth I, Strek ME, Chung JHAmerican journal of respiratory and critical care medicinePrognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation. Am J Respir Crit Care Med. 2019 03 15; 199(6):747-759.Am J Respir Crit Care Med2019-03-15T00:00:002019Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation.28864644Sharma N, Putman MS, Vij R, Strek ME, Dua AThe Journal of rheumatologyMyositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort. J Rheumatol. 2017 Nov; 44(11):1612-1618.J Rheumatol2017-09-01T00:00:002017Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort.29085824Adegunsoye A, Oldham JM, Husain AN, Chen L, Hsu S, Montner S, Chung JH, Vij R, Noth I, Strek MEFrontiers in medicineAutoimmune Hypothyroidism As a Predictor of Mortality in Chronic Hypersensitivity Pneumonitis. Front Med (Lausanne). 2017; 4:170.Front Med (Lausanne)2017-10-16T00:00:002017Autoimmune Hypothyroidism As a Predictor of Mortality in Chronic Hypersensitivity Pneumonitis.28845429Adegunsoye A, Oldham JM, Fernández Pérez ER, Hamblin M, Patel N, Tener M, Bhanot D, Robinson L, Bullick S, Chen L, Hsu S, Churpek M, Hedeker D, Montner S, Chung JH, Husain AN, Noth I, Strek ME, Vij RERJ open researchOutcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis. ERJ Open Res. 2017 Jul; 3(3).ERJ Open Res2017-08-17T00:00:002017Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis.29890565Strek MERespirology (Carlton, Vic.)Systemic sclerosis-associated interstitial lung disease: Role of the oesophagus in outcomes. Respirology. 2018 10; 23(10):885-886.Respirology2018-06-11T00:00:002018Systemic sclerosis-associated interstitial lung disease: Role of the oesophagus in outcomes.28867295Bonham CA, Patterson KC, Strek MEChestAsthma Outcomes and Management During Pregnancy. Chest. 2018 02; 153(2):515-527.Chest2017-09-01T00:00:002017Asthma Outcomes and Management During Pregnancy.Authorship 125745730578333Richeldi L, Varone F, Bergna M, de Andrade J, Falk J, Hallowell R, Jouneau S, Kondoh Y, Morrow L, Randerath W, Strek M, Tabaj GEuropean respiratory review : an official journal of the European Respiratory SocietyPharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence. Eur Respir Rev. 2018 Dec 31; 27(150).Eur Respir Rev2018-12-21T00:00:002018Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.Authorship 1263212Authorship 126320230604506Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SCArthritis & rheumatology (Hoboken, N.J.)Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Arthritis Rheumatol. 2019 02; 71(2):182-195.Arthritis Rheumatol2019-01-03T00:00:002019Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.30605544Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SCQJM : monthly journal of the Association of PhysiciansProceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. QJM. 2019 02 01; 112(2):81-93.QJM2019-02-01T00:00:002019Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.Authorship 126567930635297Newton CA, Oldham JM, Ley B, Anand V, Adegunsoye A, Liu G, Batra K, Torrealba J, Kozlitina J, Glazer C, Strek ME, Wolters PJ, Noth I, Garcia CKThe European respiratory journalTelomere length and genetic variant associations with interstitial lung disease progression and survival. Eur Respir J. 2019 04; 53(4).Eur Respir J2019-04-11T00:00:002019Telomere length and genetic variant associations with interstitial lung disease progression and survival.Authorship 1267215Authorship 126660830653927Adegunsoye A, Oldham JM, Bellam SK, Montner S, Churpek MM, Noth I, Vij R, Strek ME, Chung JHAnnals of the American Thoracic SocietyComputed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases. Ann Am Thorac Soc. 2019 05; 16(5):580-588.Ann Am Thorac Soc2019-05-01T00:00:002019Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.30653922Adegunsoye A, Oldham JM, Sperling AI, Noth I, Strek ME, Chung JHAmerican journal of respiratory and critical care medicineReply to Lescoat et al. and to Khamis et al. Am J Respir Crit Care Med. 2019 04 15; 199(8):1041-1042.Am J Respir Crit Care Med2019-04-15T00:00:002019Reply to Lescoat et al. and to Khamis et al.Authorship 127003930665514Bermea RS, Adegunsoye A, Oldham J, Ventura I, Lee C, Chung JH, Montner S, Noth I, Strek ME, Vij RRespiratory medicineAnti-RNA binding protein positivity in idiopathic interstitial pneumonia. Respir Med. 2019 01; 146:23-27.Respir Med2018-11-22T00:00:002018Anti-RNA binding protein positivity in idiopathic interstitial pneumonia.Authorship 107162Authorship 112012Authorship 115961Authorship 115781Authorship 123961Authorship 16001Authorship 1293065131034279Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, Cho MH, James JA, Guthridge JM, Cogan JD, Kropski JA, Swigris JJ, Bair C, Kim DS, Ji W, Kim H, Song JW, Maier LA, Pacheco KA, Hirani N, Poon AS, Li F, Jenkins RG, Braybrooke R, Saini G, Maher TM, Molyneaux PL, Saunders P, Zhang Y, Gibson KF, Kass DJ, Rojas M, Sembrat J, Wolters PJ, Collard HR, Sundy JS, O'Riordan T, Strek ME, Noth I, Ma SF, Porteous MK, Kreider ME, Patel NB, Inoue Y, Hirose M, Arai T, Akagawa S, Eickelberg O, Fernandez IE, Behr J, Mogulkoc N, Corte TJ, Glaspole I, Tomassetti S, Ravaglia C, Poletti V, Crestani B, Borie R, Kannengiesser C, Parfrey H, Fiddler C, Rassl D, Molina-Molina M, Machahua C, Worboys AM, Gudmundsson G, Isaksson HJ, Lederer DJ, Podolanczuk AJ, Montesi SB, Bendstrup E, Danchel V, Selman M, Pardo A, Henry MT, Keane MP, Doran P, Vašáková M, Sterclova M, Ryerson CJ, Wilcox PG, Okamoto T, Furusawa H, Miyazaki Y, Laurent G, Baltic S, Prele C, Moodley Y, Shea BS, Ohta K, Suzukawa M, Narumoto O, Nathan SD, Venuto DC, Woldehanna ML, Kokturk N, de Andrade JA, Luckhardt T, Kulkarni T, Bonella F, Donnelly SC, McElroy A, Armstong ME, Aranda A, Carbone RG, Puppo F, Beckman KB, Nickerson DA, Fingerlin TE, Schwartz DAAmerican journal of respiratory and critical care medicineResequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 07 15; 200(2):199-208.Am J Respir Crit Care Med2019-07-15T00:00:002019Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.Authorship 19146131181198Liu GY, Ventura IB, Achtar-Zadeh N, Elicker BM, Jones KD, Wolters PJ, Collard HR, Adegunsoye A, Strek ME, Ley BChestPrevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis. Chest. 2019 10; 156(4):715-723.Chest2019-06-07T00:00:002019Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis.Authorship 1300449Authorship 131832231343258Lee CT, Strek MEAmerican journal of respiratory and critical care medicineOccupational Burden in Chronic Respiratory Disease: Call for Recognition, Training, and Data Capture. Am J Respir Crit Care Med. 2019 12 15; 200(12):1558-1559.Am J Respir Crit Care Med2019-12-15T00:00:002019Occupational Burden in Chronic Respiratory Disease: Call for Recognition, Training, and Data Capture.Authorship 220892Authorship 287883Authorship 25843Authorship 132762231492155Maher TM, Strek MERespiratory researchAntifibrotic therapy for idiopathic pulmonary fibrosis: time to treat. Respir Res. 2019 Sep 06; 20(1):205.Respir Res2019-09-06T00:00:002019Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat.Authorship 132960931524503Alqalyoobi S, Adegunsoye A, Linderholm A, Hrusch C, Cutting C, Ma SF, Sperling A, Noth I, Strek ME, Oldham JMAmerican journal of respiratory and critical care medicineCirculating Plasma Biomarkers of Progressive Interstitial Lung Disease. Am J Respir Crit Care Med. 2020 01 15; 201(2):250-253.Am J Respir Crit Care Med2020-01-15T00:00:002020Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease.Authorship 289921Authorship 134159231678077Schoettler N, Strek MEChestRecent Advances in Severe Asthma: From Phenotypes to Personalized Medicine. Chest. 2020 03; 157(3):516-528.Chest2019-10-31T00:00:002019Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine.Authorship 13423331Authorship 134323931710517Allen RJ, Guillen-Guio B, Oldham JM, Ma SF, Dressen A, Paynton ML, Kraven LM, Obeidat M, Li X, Ng M, Braybrooke R, Molina-Molina M, Hobbs BD, Putman RK, Sakornsakolpat P, Booth HL, Fahy WA, Hart SP, Hill MR, Hirani N, Hubbard RB, McAnulty RJ, Millar AB, Navaratnam V, Oballa E, Parfrey H, Saini G, Whyte MKB, Zhang Y, Kaminski N, Adegunsoye A, Strek ME, Neighbors M, Sheng XR, Gudmundsson G, Gudnason V, Hatabu H, Lederer DJ, Manichaikul A, Newell JD, O'Connor GT, Ortega VE, Xu H, Fingerlin TE, Bossé Y, Hao K, Joubert P, Nickle DC, Sin DD, Timens W, Furniss D, Morris AP, Zondervan KT, Hall IP, Sayers I, Tobin MD, Maher TM, Cho MH, Hunninghake GM, Schwartz DA, Yaspan BL, Molyneaux PL, Flores C, Noth I, Jenkins RG, Wain LVAmerican journal of respiratory and critical care medicineGenome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2020 03 01; 201(5):564-574.Am J Respir Crit Care Med2020-03-01T00:00:002020Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.31718645Pritchard D, Adegunsoye A, Lafond E, Pugashetti JV, DiGeronimo R, Boctor N, Sarma N, Pan I, Strek M, Kadoch M, Chung JH, Oldham JMRespiratory researchDiagnostic test interpretation and referral delay in patients with interstitial lung disease. Respir Res. 2019 Nov 12; 20(1):253.Respir Res2019-11-12T00:00:002019Diagnostic test interpretation and referral delay in patients with interstitial lung disease.Authorship 386002Authorship 495632Authorship 455218Authorship 135835332059958Jablonski R, Bhorade S, Strek ME, Dematte JChestRecognition and Management of Myositis-Associated Rapidly Progressive Interstitial Lung Disease. Chest. 2020 07; 158(1):252-263.Chest2020-02-12T00:00:002020Recognition and Management of Myositis-Associated Rapidly Progressive Interstitial Lung Disease.Authorship 136672132265340Strek METhoraxGender in idiopathic pulmonary fibrosis diagnosis: time to address unconscious bias. Thorax. 2020 05; 75(5):365-366.Thorax2020-04-07T00:00:002020Gender in idiopathic pulmonary fibrosis diagnosis: time to address unconscious bias.Authorship 413312Authorship 13771911Authorship 13775711Authorship 137819832450237Adegunsoye A, Neborak JM, Zhu D, Cantrill B, Garcia N, Oldham JM, Noth I, Vij R, Kuzniar TJ, Bellam SK, Strek ME, Mokhlesi BChestCPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA. Chest. 2020 10; 158(4):1701-1712.Chest2020-05-22T00:00:002020CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA.32455343Bonham CA, Hrusch CL, Blaine KM, Manns ST, Vij R, Oldham JM, Churpek MM, Strek ME, Noth I, Sperling AIRespiratory medicine: XT cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival. Respir Med X. 2019; 1.Respir Med X2019-02-01T00:00:002019T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival.32450241Adegunsoye A, Alqalyoobi S, Linderholm A, Bowman WS, Lee CT, Pugashetti JV, Sarma N, Ma SF, Haczku A, Sperling A, Strek ME, Noth I, Oldham JMChestCirculating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis. Chest. 2020 10; 158(4):1526-1534.Chest2020-05-22T00:00:002020Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis.Authorship 449173Authorship 474063Authorship 498021AyodejiAdegunsoyeAyodeji Adegunsoye41.7886000000000087.598699999999993924Adegunsoye, AyodejiAssistant ProfessorAuthorship 1392131532675203Graham J, Bauer Ventura I, Newton CA, Lee C, Boctor N, Pugashetti JV, Cutting C, Joerns E, Sandhu H, Chung JH, Garcia CK, Kadoch M, Noth I, Adegunsoye A, Strek ME, Oldham JMThe European respiratory journalMyositis-specific Antibodies Identify A Distinct Interstitial Pneumonia with Autoimmune Features Phenotype. Eur Respir J. 2020 Jul 16.Eur Respir J2020-07-16T00:00:002020Myositis-specific Antibodies Identify A Distinct Interstitial Pneumonia with Autoimmune Features Phenotype.Authorship 139313432687800Kawano-Dourado L, Glassberg MK, Molina-Molina M, Strek ME, Wijsenbeek M, Johannson KAThe Lancet. Respiratory medicineGender equity in interstitial lung disease. Lancet Respir Med. 2020 09; 8(9):842-843.Lancet Respir Med2020-07-17T00:00:002020Gender equity in interstitial lung disease.Authorship 1397222032743594Strohbehn GW, Heiss BL, Rouhani SJ, Trujillo JA, Yu J, Kacew AJ, Higgs EF, Bloodworth JC, Cabanov A, Wright RC, Koziol A, Weiss A, Danahey K, Karrison TG, Edens CC, Ventura IB, Pettit NN, Patel B, Pisano J, Strek ME, Gajewski TF, Ratain MJ, Reid PDmedRxiv : the preprint server for health sciencesCOVIDOSE: Low-dose tocilizumab in the treatment of Covid-19. medRxiv. 2020 Jul 26.medRxiv2020-07-26T00:00:002020COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19.Authorship 411838387540White SR, Strek ME, Kulp GV, Spaethe SM, Burch RA, Neeley SP, Leff ARThe Journal of clinical investigationRegulation of human eosinophil degranulation and activation by endogenous phospholipase A2. J Clin Invest. 1993 May; 91(5):2118-25.J Clin Invest1993-05-01T00:00:001993Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2.8498524Strek ME, White SR, Hsiue TR, Kulp GV, Williams FS, Leff ARThe American journal of physiologyEffect of mode of activation of human eosinophils on tracheal smooth muscle contraction in guinea pigs. Am J Physiol. 1993 May; 264(5 Pt 1):L475-81.Am J Physiol1993-05-01T00:00:001993Effect of mode of activation of human eosinophils on tracheal smooth muscle contraction in guinea pigs.8503558Strek ME, White SR, Ndukwu IM, Munoz NM, Williams FS, Vita AJ, Leff AR, Mitchell RWThe American review of respiratory diseasePhysiologic significance of epithelial removal on guinea pig tracheal smooth muscle response to acetylcholine and serotonin. Am Rev Respir Dis. 1993 Jun; 147(6 Pt 1):1477-82.Am Rev Respir Dis1993-06-01T00:00:001993Physiologic significance of epithelial removal on guinea pig tracheal smooth muscle response to acetylcholine and serotonin.8772536Strek ME, Williams FS, Gleich GJ, Leff AR, White SRThe American journal of physiologyMechanisms of smooth muscle contraction elicited by cationic proteins in guinea pig trachealis. Am J Physiol. 1996 Jan; 270(1 Pt 1):L133-40.Am J Physiol1996-01-01T00:00:001996Mechanisms of smooth muscle contraction elicited by cationic proteins in guinea pig trachealis.Authorship 1414092333035329Feurstein S, Adegunsoye A, Mojsilovic D, Vij R, West DePersia AH, Rajagopal PS, Osman A, Collins RH, Kim RH, Gore SD, Greenberg P, Godley LA, Li Z, Del Gaudio D, Subramanian HP, Das S, Walsh T, Gulsuner S, Segal JP, Husain AN, Gurbuxani S, King MC, Strek ME, Churpek JEBlood advancesTelomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations. Blood Adv. 2020 10 13; 4(19):4873-4886.Blood Adv2020-10-13T00:00:002020Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations.JerryKrishnanJerry A. Krishnan0.000000000000000.000000000000003070Krishnan, JerryASSOCIATE PROFESSORAuthorship 141746633122338Adegunsoye A, Morisset J, Newton CA, Oldham JM, Vittinghoff E, Linderholm AL, Strek ME, Noth I, Garcia CK, Wolters PJ, Ley BThe European respiratory journalLeukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis. Eur Respir J. 2021 03; 57(3).Eur Respir J2021-03-04T00:00:002021Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis.11426916Strek ME, Antileukotriene Working GroupAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & ImmunologyConsensus guidelines for asthma therapy. Ann Allergy Asthma Immunol. 2001 Jun; 86(6 Suppl 1):40-4.Ann Allergy Asthma Immunol2001-06-01T00:00:002001Consensus guidelines for asthma therapy.Authorship 14206920Authorship 1421461033238466Crews MS, Bartholmai BJ, Adegunsoye A, Oldham JM, Montner SM, Karwoski RA, Husain AN, Vij R, Noth I, Strek ME, Chung JHJournal of clinical medicineAutomated CT Analysis of Major Forms of Interstitial Lung Disease. J Clin Med. 2020 Nov 23; 9(11).J Clin Med2020-11-23T00:00:002020Automated CT Analysis of Major Forms of Interstitial Lung Disease.33210302Strohbehn GW, Heiss BL, Rouhani SJ, Trujillo JA, Yu J, Kacew AJ, Higgs EF, Bloodworth JC, Cabanov A, Wright RC, Koziol AK, Weiss A, Danahey K, Karrison TG, Edens CC, Bauer Ventura I, Pettit NN, Patel BK, Pisano J, Strek ME, Gajewski TF, Ratain MJ, Reid PDClinical pharmacology and therapeuticsCOVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.Clin Pharmacol Ther2020-12-10T00:00:002020COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia.12598156Noth I, Strek ME, Leff ARLancet (London, England)Churg-Strauss syndrome. Lancet. 2003 Feb 15; 361(9357):587-94.Lancet2003-02-15T00:00:002003Churg-Strauss syndrome.Medicine-Pulmonary and Critical CareRadiology-Thoracic Imaging2018147Munoz NM, Kirchhoff CF, Strek ME, Blumenthal RN, Leff ARThe American journal of physiologyEffects of PAF on isolated rat airways perfused with blood-free solution. Am J Physiol. 1991 Apr; 260(4 Pt 1):L260-7.Am J Physiol1991-04-01T00:00:001991Effects of PAF on isolated rat airways perfused with blood-free solution.16424413Rennard SI, Schachter N, Strek M, Rickard K, Amit OChestCilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4. Chest. 2006 Jan; 129(1):56-66.Chest2006-01-01T00:00:002006Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.16493159Strek MEProceedings of the American Thoracic SocietyDifficult asthma. Proc Am Thorac Soc. 2006; 3(1):116-23.Proc Am Thorac Soc2006-01-01T00:00:002006Difficult asthma.Authorship 144610933621598Lee CT, Adegunsoye A, Chung JH, Ventura IB, Jablonski R, Montner S, Vij R, Hines SE, Strek MEChestCharacteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases. Chest. 2021 07; 160(1):209-218.Chest2021-02-20T00:00:002021Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases.Authorship 1448711133689671Huang Y, Oldham JM, Ma SF, Unterman A, Liao SY, Barros AJ, Bonham CA, Kim JS, Vij R, Adegunsoye A, Strek ME, Molyneaux PL, Maher TM, Herazo-Maya JD, Kaminski N, Moore BB, Martinez FJ, Noth IAmerican journal of respiratory and critical care medicineBlood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells. Am J Respir Crit Care Med. 2021 07 15; 204(2):197-208.Am J Respir Crit Care Med2021-07-15T00:00:002021Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells.Authorship 145897933847810Chung JH, Adegunsoye A, Oldham JM, Vij R, Husain A, Montner SM, Karwoski RA, Bartholmai BJ, Strek MEEuropean radiologyVessel-related structures predict UIP pathology in those with a non-IPF pattern on CT. Eur Radiol. 2021 Oct; 31(10):7295-7302.Eur Radiol2021-04-13T00:00:002021Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT.19590436Mileti LM, Strek ME, Niewold TB, Curran JJ, Sweiss NJJournal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseasesClinical characteristics of patients with anti-Jo-1 antibodies: a single center experience. J Clin Rheumatol. 2009 Aug; 15(5):254-5.J Clin Rheumatol2009-08-01T00:00:002009Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience.20463254Patterson K, Strek MEProceedings of the American Thoracic SocietyAllergic bronchopulmonary aspergillosis. Proc Am Thorac Soc. 2010 May; 7(3):237-44.Proc Am Thorac Soc2010-05-01T00:00:002010Allergic bronchopulmonary aspergillosis.21565966Vij R, Noth I, Strek MEChestAutoimmune-featured interstitial lung disease: a distinct entity. Chest. 2011 Nov; 140(5):1292-1299.Chest2011-05-12T00:00:002011Autoimmune-featured interstitial lung disease: a distinct entity.Authorship 146502933974150Chung JH, Adegunsoye A, Oldham JM, Vij R, Husain A, Montner SM, Karwoski RA, Bartholmai BJ, Strek MEEuropean radiologyCorrection to: Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT. Eur Radiol. 2021 Nov; 31(11):8825.Eur Radiol2021-11-01T00:00:002021Correction to: Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT.21737563Noth I, Zangan SM, Soares RV, Forsythe A, Demchuk C, Takahashi SM, Patel SB, Strek ME, Krishnan JA, Patti MG, Macmahon HThe European respiratory journalPrevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2012 Feb; 39(2):344-51.Eur Respir J2011-07-07T00:00:002011Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis.23131929Strek MEChestImproving asthma management: time for an action plan. Chest. 2012 Nov; 142(5):1085-1087.Chest2012-11-01T00:00:002012Improving asthma management: time for an action plan.22267679McShane PJ, Naureckas ET, Strek MEChestBronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture. Chest. 2012 Jul; 142(1):159-167.Chest2012-07-01T00:00:002012Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture.23020731Cipriani NA, Strek M, Noth I, Gordon IO, Charbeneau J, Krishnan JA, Krausz T, Husain ANArchives of pathology & laboratory medicinePathologic quantification of connective tissue disease-associated versus idiopathic usual interstitial pneumonia. Arch Pathol Lab Med. 2012 Oct; 136(10):1253-8.Arch Pathol Lab Med2012-10-01T00:00:002012Pathologic quantification of connective tissue disease-associated versus idiopathic usual interstitial pneumonia.Authorship 147241234127620Lee CT, Strek MECurrent opinion in pulmonary medicineThe other connective tissue disease-associated interstitial lung diseases: Sjogren's syndrome, mixed connective tissue disease, and systemic lupus erythematosus. Curr Opin Pulm Med. 2021 09 01; 27(5):388-395.Curr Opin Pulm Med2021-09-01T00:00:002021The other connective tissue disease-associated interstitial lung diseases: Sjogren's syndrome, mixed connective tissue disease, and systemic lupus erythematosus.Authorship 14770412Authorship 1476951734197782Hunninghake GM, Goldin JG, Kadoch MA, Kropski JA, Rosas IO, Wells AU, Yadav R, Lazarus HM, Abtin FG, Corte TJ, de Andrade JA, Johannson KA, Kolb MR, Lynch DA, Oldham JM, Spagnolo P, Strek ME, Tomassetti S, Washko GR, White ES, ILA Study GroupChestDetection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative. Chest. 2022 02; 161(2):470-482.Chest2021-06-29T00:00:002021Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.34204184Chung JH, Adegunsoye A, Cannon B, Vij R, Oldham JM, King C, Montner SM, Thirkateh P, Barnett S, Karwoski R, Bartholmai BJ, Strek M, Nathan SDJournal of clinical medicineDifferentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging. J Clin Med. 2021 Jun 17; 10(12).J Clin Med2021-06-17T00:00:002021Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging.Authorship 148206534293188Barnes H, Troy L, Lee CT, Sperling A, Strek M, Glaspole IAllergyHypersensitivity pneumonitis: Current concepts in pathogenesis, diagnosis, and treatment. Allergy. 2022 02; 77(2):442-453.Allergy2021-07-29T00:00:002021Hypersensitivity pneumonitis: Current concepts in pathogenesis, diagnosis, and treatment.2745342Ray DW, Ingenito EP, Strek M, Schumacker PT, Solway JJournal of applied physiology (Bethesda, Md. : 1985)Longitudinal distribution of canine respiratory heat and water exchanges. J Appl Physiol (1985). 1989 Jun; 66(6):2788-98.J Appl Physiol (1985)1989-06-01T00:00:001989Longitudinal distribution of canine respiratory heat and water exchanges.8214090Hamann KJ, Strek ME, Baranowski SL, Munoz NM, Williams FS, White SR, Vita A, Leff ARThe American journal of physiologyEffects of activated eosinophils cultured from human umbilical cord blood on guinea pig trachealis. Am J Physiol. 1993 Sep; 265(3 Pt 1):L301-7.Am J Physiol1993-09-01T00:00:001993Effects of activated eosinophils cultured from human umbilical cord blood on guinea pig trachealis.Authorship 150055834592998Kim HJ, Snyder LD, Adegunsoye A, Neely ML, Bender S, White ES, Conoscenti CS, Strek ME, IPF-PRO Registry InvestigatorsRespiratory researchHospitalizations in patients with idiopathic pulmonary fibrosis. Respir Res. 2021 Sep 30; 22(1):257.Respir Res2021-09-30T00:00:002021Hospitalizations in patients with idiopathic pulmonary fibrosis.1596019Strek ME, Garland A, Abrahams C, Leff AR, White SRThe American review of respiratory diseaseDirect effects and augmentation of airway smooth muscle contraction caused by phospholipase A2. Am Rev Respir Dis. 1992 Jun; 145(6):1463-8.Am Rev Respir Dis1992-06-01T00:00:001992Direct effects and augmentation of airway smooth muscle contraction caused by phospholipase A2.Authorship 151147834755024D'Silva KM, Ventura IB, Bolster MB, Castelino FV, Sharma A, Little BP, Adegunsoye A, Strek ME, Choi H, Montesi SBRheumatology advances in practiceRituximab for interstitial pneumonia with autoimmune features at two medical centres. Rheumatol Adv Pract. 2021 Nov; 5(Suppl 2):ii1-ii9.Rheumatol Adv Pract2021-11-05T00:00:002021Rituximab for interstitial pneumonia with autoimmune features at two medical centres.Authorship 1512286Authorship 15125914Authorship 151289934819525Tyker A, Ventura IB, Lee CT, Strykowski R, Garcia N, Guzy R, Jablonski R, Vij R, Strek ME, Chung JH, Adegunsoye AScientific reportsHigh-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease. Sci Rep. 2021 11 24; 11(1):22821.Sci Rep2021-11-24T00:00:002021High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.34737223Oldham JM, Lee CT, Wu Z, Bowman WS, Pugashetti JV, Dao N, Tonkin J, Seede H, Echt G, Adegunsoye A, Chua F, Maher TM, Garcia CK, Strek ME, Newton CA, Molyneaux PLThe European respiratory journalLung function trajectory in progressive fibrosing interstitial lung disease. Eur Respir J. 2022 06; 59(6).Eur Respir J2022-06-16T00:00:002022Lung function trajectory in progressive fibrosing interstitial lung disease.34761002Biblowitz K, Lee C, Zhu D, Noth I, Vij R, Strek ME, Bellam SK, Adegunsoye AERJ open researchAssociation of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease. ERJ Open Res. 2021 Oct; 7(4).ERJ Open Res2021-11-08T00:00:002021Association of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease.Authorship 153394235254944Lee CT, Strek MEAnnals of the American Thoracic SocietyOccupational Exposures in Rheumatoid Arthritis-related Airway Disease: A Missing Link? Ann Am Thorac Soc. 2022 06; 19(6):1076-1077.Ann Am Thorac Soc2022-06-01T00:00:002022Occupational Exposures in Rheumatoid Arthritis-related Airway Disease: A Missing Link?Authorship 153588535337809Lee J, White E, Freiheit E, Scholand MB, Strek ME, Podolanczuk AJ, Patel NM, Pulmonary Fibrosis FoundationChestCough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry. Chest. 2022 09; 162(3):603-613.Chest2022-03-23T00:00:002022Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry.Authorship 15411210Authorship 1544041535386918Lee CT, Ventura IB, Phillips EK, Leahy A, Jablonski R, Montner S, Chung JH, Vij R, Adegunsoye A, Strek MEFrontiers in medicineInterstitial Lung Disease in Firefighters: An Emerging Occupational Hazard. Front Med (Lausanne). 2022; 9:864658.Front Med (Lausanne)2022-03-21T00:00:002022Interstitial Lung Disease in Firefighters: An Emerging Occupational Hazard.35486072Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, Kreuter M, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers JL, Nicholson AG, Ryerson CJ, Strek ME, Troy LK, Wijsenbeek M, Mammen MJ, Hossain T, Bissell BD, Herman DD, Hon SM, Kheir F, Khor YH, Macrea M, Antoniou KM, Bouros D, Buendia-Roldan I, Caro F, Crestani B, Ho L, Morisset J, Olson AL, Podolanczuk A, Poletti V, Selman M, Ewing T, Jones S, Knight SL, Ghazipura M, Wilson KCAmerican journal of respiratory and critical care medicineIdiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022 05 01; 205(9):e18-e47.Am J Respir Crit Care Med2022-05-01T00:00:002022Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.Authorship 154481235512793Lee CT, Strek ME, Adegunsoye A, Wong AW, Assayag D, Cox G, Fell CD, Fisher JH, Gershon AS, Halayko AJ, Hambly N, Khalil N, Kolb M, Lok SD, Manganas H, Marcoux V, Morisset J, Sadatsafavi M, Shapera S, To T, Wilcox P, Ryerson CJ, Johannson KARespirology (Carlton, Vic.)Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis. Respirology. 2022 08; 27(8):635-644.Respirology2022-05-05T00:00:002022Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis.Authorship 154822935530871Strykowski RK, Poonawalla M, Tyker A, Bauer Ventura I, Lee C, Jablonski R, Vij R, Chung J, Strek M, Adegunsoye ACureusMortality Risk From COVID-19 Among Unvaccinated Subjects With Autoimmune Phenotypes of Interstitial Lung Disease. Cureus. 2022 Apr; 14(4):e23808.Cureus2022-04-04T00:00:002022Mortality Risk From COVID-19 Among Unvaccinated Subjects With Autoimmune Phenotypes of Interstitial Lung Disease.D017563Disorders462340.767125Lung Diseases, InterstitialAuthorship 1595318Authorship 15982819Authorship 1583422635985358Allen RJ, Oldham JM, Jenkins DA, Leavy OC, Guillen-Guio B, Melbourne CA, Ma SF, Jou J, Kim JS, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative, Fahy WA, Oballa E, Hubbard RB, Navaratnam V, Braybrooke R, Saini G, Roach KM, Tobin MD, Hirani N, Whyte MKB, Kaminski N, Zhang Y, Martinez FJ, Linderholm AL, Adegunsoye A, Strek ME, Maher TM, Molyneaux PL, Flores C, Noth I, Gisli Jenkins R, Wain LVThe Lancet. Respiratory medicineLongitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study. Lancet Respir Med. 2023 01; 11(1):65-73.Lancet Respir Med2022-08-16T00:00:002022Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study.36624431Rahaghi FF, Hsu VM, Kaner RJ, Mayes MD, Rosas IO, Saggar R, Steen VD, Strek ME, Bernstein EJ, Bhatt N, Castelino FV, Chung L, Domsic RT, Flaherty KR, Gupta N, Kahaleh B, Martinez FJ, Morrow LE, Moua T, Patel N, Shlobin OA, Southern BD, Volkmann ER, Khanna DRespiratory researchExpert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respir Res. 2023 Jan 09; 24(1):6.Respir Res2023-01-09T00:00:002023Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.36621759Assayag D, Adegunsoye A, Sheehy R, Morisset J, Khalil N, Johannson KA, Marcoux V, Kolb M, Fisher JH, Manganas H, Wrobel J, Wilsher M, De Boer S, Mackintosh J, Chambers DC, Glaspole I, Keir GJ, Lee CT, Jablonski R, Vij R, Strek ME, Corte TJ, Ryerson CJChestSex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia. Chest. 2023 05; 163(5):1156-1165.Chest2023-01-05T00:00:002023Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia.University of Chicago20142013Arthur H. Rubenstein Department of Medicine Mentoring AwardUniversity of Chicago20142013Biological Sciences Division Senior Mentoring Award23898922McShane PJ, Naureckas ET, Tino G, Strek MEAmerican journal of respiratory and critical care medicineNon-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013 Sep 15; 188(6):647-56.Am J Respir Crit Care Med2013-09-15T00:00:002013Non-cystic fibrosis bronchiectasis.24751453Sweiss NJ, Noth I, Mirsaeidi M, Zhang W, Naureckas ET, Hogarth DK, Strek M, Caligiuri P, Machado RF, Niewold TB, Garcia JG, Pangan AL, Baughman RPSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOGEfficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18; 31(1):46-54.Sarcoidosis Vasc Diffuse Lung Dis2014-04-18T00:00:002014Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.Authorship 1610051736780644Oldham JM, Allen RJ, Lorenzo-Salazar JM, Molyneaux PL, Ma SF, Joseph C, Kim JS, Guillen-Guio B, Hernández-Beeftink T, Kropski JA, Huang Y, Lee CT, Adegunsoye A, Pugashetti JV, Linderholm AL, Vo V, Strek ME, Jou J, Muñoz-Barrera A, Rubio-Rodriguez LA, Hubbard R, Hirani N, Whyte MKB, Hart S, Nicholson AG, Lancaster L, Parfrey H, Rassl D, Wallace W, Valenzi E, Zhang Y, Mychaleckyj J, Stockwell A, Kaminski N, Wolters PJ, Molina-Molina M, Banovich NE, Fahy WA, Martinez FJ, Hall IP, Tobin MD, Maher TM, Blackwell TS, Yaspan BL, Jenkins RG, Flores C, Wain LV, Noth IAmerican journal of respiratory and critical care medicinePCSK6 and Survival in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023 06 01; 207(11):1515-1524.Am J Respir Crit Care Med2023-06-01T00:00:002023PCSK6 and Survival in Idiopathic Pulmonary Fibrosis.D054990Disorders391640.825391Idiopathic Pulmonary FibrosisAuthorship 1613981636897590Adegunsoye A, Freiheit E, White EN, Kaul B, Newton CA, Oldham JM, Lee CT, Chung J, Garcia N, Ghodrati S, Vij R, Jablonski R, Flaherty KR, Wolters PJ, Garcia CK, Strek MEJAMA network openEvaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults. JAMA Netw Open. 2023 03 01; 6(3):e232427.JAMA Netw Open2023-03-01T00:00:002023Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults.https://biomedsciences.uchicago.edu/page/anne-i-sperling-phdUChicago Biohttps://rubinlab.uchicago.edu/Rubin Lab Sitehttps://www.uchicagomedicine.org/conditions-services/inflammatory-bowel-diseaseInflammatory Bowel Disease Centerhttp://chicagoitm.orgUChicago-Rush Institute for Translational MedicineIBDMDdrdayjeeD011658Disorders471230.87189Pulmonary FibrosisAuthorship 16223619Authorship 1632101336932145Adegunsoye A, Newton CA, Oldham JM, Ley B, Lee CT, Linderholm AL, Chung JH, Garcia N, Zhang D, Vij R, Guzy R, Jablonski R, Bag R, Voogt RS, Ma SF, Sperling AI, Raghu G, Martinez FJ, Strek ME, Wolters PJ, Garcia CK, Pierce BL, Noth INature communicationsTelomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts. Nat Commun. 2023 03 17; 14(1):1489.Nat Commun2023-03-17T00:00:002023Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts.37163026Upadhyay V, Yoon YM, Vazquez SE, Velez TE, Jones KD, Lee CT, Law CS, Wolters PJ, Lee S, Yang MM, Farrand E, Noth I, Strek ME, Anderson M, DeRisi J, Sperling AI, Shum AKbioRxiv : the preprint server for biologyPhIP-Seq uncovers novel autoantibodies and unique endotypes in interstitial lung disease. bioRxiv. 2023 Apr 24.bioRxiv2023-04-24T00:00:002023PhIP-Seq uncovers novel autoantibodies and unique endotypes in interstitial lung disease.Authorship 16370510Authorship 16401815Authorship 16421312Authorship 16388113Authorship 164067337214861Yoon YM, Velez TE, Upadhyay V, Vazquez SE, Lee CT, Selvan KC, Law CS, Blaine KM, Hollinger MK, Decker DC, Clark MR, Strek ME, Guzy RD, Adegunsoye A, Noth I, Wolters PJ, Anderson M, DeRisi JL, Shum AK, Sperling AImedRxiv : the preprint server for health sciencesAntigenic responses are hallmarks of fibrotic interstitial lung diseases independent of underlying etiologies. medRxiv. 2023 May 11.medRxiv2023-05-11T00:00:002023Antigenic responses are hallmarks of fibrotic interstitial lung diseases independent of underlying etiologies.37263752Khor YH, Cottin V, Holland AE, Inoue Y, McDonald VM, Oldham J, Renzoni EA, Russell AM, Strek ME, Ryerson CJThe European respiratory journalTreatable traits: a comprehensive precision medicine approach in interstitial lung disease. Eur Respir J. 2023 07; 62(1).Eur Respir J2023-07-27T00:00:002023Treatable traits: a comprehensive precision medicine approach in interstitial lung disease.37344825Ruan P, Todd JL, Zhao H, Liu Y, Vinisko R, Soellner JF, Schmid R, Kaner RJ, Luckhardt TR, Neely ML, Noth I, Porteous M, Raj R, Safdar Z, Strek ME, Hesslinger C, Palmer SM, Leonard TB, Salisbury MLRespiratory researchIntegrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression. Respir Res. 2023 May 31; 24(1):141.Respir Res2023-05-31T00:00:002023Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression.37366539Douglas D, Keating L, Strykowski R, Lee CT, Garcia N, Selvan K, Kaushik N, Bauer Ventura I, Jablonski R, Vij R, Chung JH, Bellam S, Strek ME, Adegunsoye AAmerican journal of physiology. Lung cellular and molecular physiologyTobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2023 08 01; 325(2):L233-L243.Am J Physiol Lung Cell Mol Physiol2023-06-27T00:00:002023Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease.37385460Stahlbaum D, Jablonski R, Strek ME, Bestvina CM, Polley MY, Reid PRespiratory medicineAbnormalities on baseline chest imaging are risk factors for immune checkpoint inhibitor associated pneumonitis. Respir Med. 2023 Oct; 217:107330.Respir Med2023-06-28T00:00:002023Abnormalities on baseline chest imaging are risk factors for immune checkpoint inhibitor associated pneumonitis.MedicineRadiologyUniversity of ChicagoJasonPostonJason Poston41.78927490000000-87.601250000000001072Poston, JasonAssociate ProfessorJohn P.Kress3Wl7DrIGOfnamXNnYUHhvWD+6g==John P. Kress41.78927490000000-87.601250000000001303Kress, John P.Professor37591536Zhang D, Adegunsoye A, Oldham JM, Kozlitina J, Garcia N, Poonawalla M, Strykowski R, Linderholm AL, Ley B, Ma SF, Noth I, Strek ME, Wolters PJ, Garcia CK, Newton CAThe European respiratory journalTelomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. Eur Respir J. 2023 11; 62(5).Eur Respir J2023-11-29T00:00:002023Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.37546732Guillen-Guio B, Paynton ML, Allen RJ, Chin DPW, Donoghue LJ, Stockwell A, Leavy OC, Hernandez-Beeftink T, Reynolds C, Cullinan P, Martinez F, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative, Booth HL, Fahy WA, Hall IP, Hart SP, Hill MR, Hirani N, Hubbard RB, McAnulty RJ, Millar AB, Navaratnam V, Oballa E, Parfrey H, Saini G, Sayers I, Tobin MD, Whyte MKB, Adegunsoye A, Kaminski N, Shwu-Fan M, Strek ME, Zhang Y, Fingerlin TE, Molina-Molina M, Neighbors M, Sheng XR, Oldham JM, Maher TM, Molyneaux PL, Flores C, Noth I, Schwartz DA, Yaspan BL, Jenkins RG, Wain LV, Hollox EJmedRxiv : the preprint server for health sciencesAssociation study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosis. medRxiv. 2023 Jul 24.medRxiv2023-07-24T00:00:002023Association study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosis.Authorship 16571932Authorship 16581612University of Michigan1980James B. Angell ScholarUniversity of Chicago19931990Parker B. Francis Fellowship AwardUniversity of Chicago2014Castle Connolly "Top Doctor" AwardAuthorship 648412Authorship 648427Authorship 648432Authorship 648444Authorship 6484513Authorship 648461724836312King TE, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW, ASCEND Study GroupThe New England journal of medicineA phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014 May 29; 370(22):2083-92.N Engl J Med2014-05-18T00:00:002014A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.23648946Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, Costabel U, Richeldi L, de Andrade J, Khalil N, Morrison LD, Lederer DJ, Shao L, Li X, Pedersen PS, Montgomery AB, Chien JW, O'Riordan TG, ARTEMIS-IPF Investigators*Annals of internal medicineTreatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med. 2013 May 07; 158(9):641-9.Ann Intern Med2013-05-07T00:00:002013Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.25367472Patterson KC, Strek MEChestDiagnosis and treatment of pulmonary aspergillosis syndromes. Chest. 2014 Nov; 146(5):1358-1368.Chest2014-11-01T00:00:002014Diagnosis and treatment of pulmonary aspergillosis syndromes.23952859Patterson KC, Strek MEAnnals of the American Thoracic SocietyPulmonary fibrosis in sarcoidosis. Clinical features and outcomes. Ann Am Thorac Soc. 2013 Aug; 10(4):362-70.Ann Am Thorac Soc2013-08-01T00:00:002013Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes.JulianSolway3XFmB7YUeczMknJtY0fp/Cv/+94=Julian Solway41.78927490000000-87.601250000000001704Solway, JulianProfessorAnne I.SperlingAnne I. Sperling41.78927490000000-87.601250000000001999Sperling, Anne I.ProfessorStevenWhiteSteven White41.78927490000000-87.601250000000002172White, StevenProfessorAuthorship 1672661437847691Oldham JM, Huang Y, Bose S, Ma SF, Kim JS, Schwab A, Ting C, Mou K, Lee CT, Adegunsoye A, Ghodrati S, Vu Pugashetti J, Nazemi N, Strek ME, Linderholm AL, Chen CH, Murray S, Zemans RL, Flaherty KR, Martinez FJ, Noth IAmerican journal of respiratory and critical care medicineProteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023 Oct 17.Am J Respir Crit Care Med2023-10-17T00:00:002023Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.David T.RubinDavid T. Rubin41.78927490000000-87.60125000000000256Rubin, David T.Professor11.35190.00391193382research areas10.36320.0063496466coauthor of257.7316.878760similar to11134selected publicationsAuthorship 1677368Authorship 167812637866772Kim JS, Ma SF, Ma JZ, Huang Y, Bonham CA, Oldham JM, Adegunsoye A, Strek ME, Flaherty KR, Strickland E, Udofia I, Mooney JJ, Ghosh S, Maddipati K, Noth IChestAssociations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis. Chest. 2024 Mar; 165(3):621-631.Chest2023-10-20T00:00:002023Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis.37908551Hu-Wang E, Chelala L, Landeras L, Li H, Husain AN, Strek ME, Chung JHRadiology. Cardiothoracic imagingPulmonary Alveolar Proteinosis-associated Pulmonary Fibrosis: Evolutional Changes and Radiologic-Pathologic Correlation. Radiol Cardiothorac Imaging. 2023 Oct; 5(5):e230040.Radiol Cardiothorac Imaging2023-10-19T00:00:002023Pulmonary Alveolar Proteinosis-associated Pulmonary Fibrosis: Evolutional Changes and Radiologic-Pathologic Correlation.StevenMontnerSteven Montner41.78927490000000-87.60125000000000951Montner, StevenProfessor38199762Lee CT, Selvan K, Adegunsoye A, Strykowski RK, Parker WF, Dignam JJ, Lauderdale DS, Strek ME, Press VGRespiratory careRisk Factors for Hospital Readmission in Patients with Interstitial Lung Disease. Respir Care. 2024 Jan 10.Respir Care2024-01-10T00:00:002024Risk Factors for Hospital Readmission in Patients with Interstitial Lung Disease.38207093Humphries SM, Thieke D, Baraghoshi D, Strand MJ, Swigris JJ, Chae KJ, Hwang HJ, Oh AS, Flaherty KR, Adegunsoye A, Jablonski R, Lee CT, Husain AN, Chung JH, Strek ME, Lynch DAAmerican journal of respiratory and critical care medicineDeep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes. Am J Respir Crit Care Med. 2024 Jan 11.Am J Respir Crit Care Med2024-01-11T00:00:002024Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes.Authorship 16941815Authorship 1693958Authorship 1697687Authorship 1698033038293162Leavy OC, Goemans AF, Stockwell AD, Allen RJ, Guillen-Guio B, Hernandez-Beeftink T, Adegunsoye A, Booth HL, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative, Cullinan P, Fahy WA, Fingerlin TE, Virk HS, Hall IP, Hart SP, Hill MR, Hirani N, Hubbard RB, Kaminski N, Ma SF, McAnulty RJ, Sheng XR, Millar AB, Molina-Molina M, Navaratnam V, Neighbors M, Parfrey H, Saini G, Sayers I, Strek ME, Tobin MD, Whyte MK, Zhang Y, Maher TM, Molyneaux PL, Oldham JM, Yaspan BL, Flores C, Martinez F, Reynolds CJ, Schwartz DA, Noth I, Jenkins RG, Wain LVmedRxiv : the preprint server for health sciencesGenome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosis. medRxiv. 2024 Jan 15.medRxiv2024-01-15T00:00:002024Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosis.38290750Selvan K, Chelala L, Lee CT, Adegunsoye A, Chung JH, Jablonski R, Strek MERespiratory careImplementation of an Interstitial Lung Abnormality Clinic and Multidisciplinary Discussion. Respir Care. 2024 Jan 30.Respir Care2024-01-30T00:00:002024Implementation of an Interstitial Lung Abnormality Clinic and Multidisciplinary Discussion.Authorship 1701293138375425Guillen-Guio B, Paynton ML, Allen RJ, Chin DPW, Donoghue LJ, Stockwell A, Leavy OC, Hernandez-Beeftink T, Reynolds C, Cullinan P, Martinez F, Booth HL, Fahy WA, Hall IP, Hart SP, Hill MR, Hirani N, Hubbard RB, McAnulty RJ, Millar AB, Navaratnam V, Oballa E, Parfrey H, Saini G, Sayers I, Tobin MD, Whyte MKB, Adegunsoye A, Kaminski N, Ma SF, Strek ME, Zhang Y, Fingerlin TE, Molina-Molina M, Neighbors M, Sheng XR, Oldham JM, Maher TM, Molyneaux PL, Flores C, Noth I, Schwartz DA, Yaspan BL, Jenkins RG, Wain LV, Hollox EJERJ open researchAssociation study of human leukocyte antigen variants and idiopathic pulmonary fibrosis. ERJ Open Res. 2024 Jan; 10(1).ERJ Open Res2024-02-19T00:00:002024Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis.FurkanUfukFurkan Ufuk41.7886000000000087.598699999999994519Ufuk, FurkanAssistant ProfessorAuthorship 1706691638422478Huang Y, Ma SF, Oldham JM, Adegunsoye A, Zhu D, Murray S, Kim JS, Bonham C, Strickland E, Linderholm AL, Lee CT, Paul T, Mannem H, Maher TM, Molyneaux PL, Strek ME, Martinez FJ, Noth IAmerican journal of respiratory and critical care medicineMachine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease. Am J Respir Crit Care Med. 2024 Feb 29.Am J Respir Crit Care Med2024-02-29T00:00:002024Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease.true1ProfessorProfessortrue1ASSOCIATE PROFESSORASSOCIATE PROFESSORtrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Clinical AssociateClinical Associatetrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessor1010Authorship 81634725811599Oldham JM, Kumar D, Lee C, Patel SB, Takahashi-Manns S, Demchuk C, Strek ME, Noth IChestThyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis. Chest. 2015 Sep; 148(3):692-700.Chest2015-09-01T00:00:002015Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis.JonathanChungJonathan Chung0.000000000000000.000000000000003202Chung, JonathanClinical AssociateAuthorship 831921426160873Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, Mosca M, Noth I, Richeldi L, Strek ME, Swigris JJ, Wells AU, West SG, Collard HR, Cottin V, “ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD”The European respiratory journalAn official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015 Oct; 46(4):976-87.Eur Respir J2015-07-09T00:00:002015An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.Authorship 84423726589497Huang Y, Ma SF, Vij R, Oldham JM, Herazo-Maya J, Broderick SM, Strek ME, White SR, Hogarth DK, Sandbo NK, Lussier YA, Gibson KF, Kaminski N, Garcia JG, Noth IBMC pulmonary medicineA functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis. BMC Pulm Med. 2015 Nov 21; 15:147.BMC Pulm Med2015-11-21T00:00:002015A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.Authorship 850271226331942Oldham JM, Ma SF, Martinez FJ, Anstrom KJ, Raghu G, Schwartz DA, Valenzi E, Witt L, Lee C, Vij R, Huang Y, Strek ME, Noth I, IPFnet InvestigatorsAmerican journal of respiratory and critical care medicineTOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2015 Dec 15; 192(12):1475-82.Am J Respir Crit Care Med2015-12-15T00:00:002015TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.Authorship 85401226730865Carlos WG, Strek ME, Wang TS, Patel H, Raghu G, Wilson KC, Thomson CCAnnals of the American Thoracic SocietyTreatment of Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2016 Jan; 13(1):115-7.Ann Am Thorac Soc2016-01-01T00:00:002016Treatment of Idiopathic Pulmonary Fibrosis.Chicago60637ILAuthorship 873972Authorship 87190426762710Witt LJ, Demchuk C, Curran JJ, Strek MEPulmonary pharmacology & therapeuticsBenefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease. Pulm Pharmacol Ther. 2016 Feb; 36:46-52.Pulm Pharmacol Ther2016-01-05T00:00:002016Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease.26867838Oldham JM, Strek ME, Noth IChestResponse. Chest. 2016 Feb; 149(2):600-601.Chest2016-02-01T00:00:002016Response.Authorship 890422Authorship 89142611207010Hrabec E, Strek M, Nowak D, Hrabec ZRespiratory medicineElevated level of circulating matrix metalloproteinase-9 in patients with lung cancer. Respir Med. 2001 Jan; 95(1):1-4.Respir Med2001-01-01T00:00:002001Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer.27109811Adegunsoye A, Oldham JM, Demchuk C, Montner S, Vij R, Strek MERespiratory medicinePredictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med. 2016 05; 114:53-60.Respir Med2016-03-21T00:00:002016Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features.Authorship 902181427103387Oldham JM, Adegunsoye A, Valenzi E, Lee C, Witt L, Chen L, Husain AN, Montner S, Chung JH, Cottin V, Fischer A, Noth I, Vij R, Strek METhe European respiratory journalCharacterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J. 2016 06; 47(6):1767-75.Eur Respir J2016-04-21T00:00:002016Characterisation of patients with interstitial pneumonia with autoimmune features.Authorship 924661Authorship 92474227379968Strek ME, Costabel UCurrent opinion in pulmonary medicineInterstitial pneumonia with autoimmune features: a critical appraisal of the new definition. Curr Opin Pulm Med. 2016 09; 22(5):442-9.Curr Opin Pulm Med2016-09-01T00:00:002016Interstitial pneumonia with autoimmune features: a critical appraisal of the new definition.27379967Bonham CA, Strek ME, Patterson KCCurrent opinion in pulmonary medicineFrom granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis. Curr Opin Pulm Med. 2016 09; 22(5):484-91.Curr Opin Pulm Med2016-09-01T00:00:002016From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis.Authorship 602109Authorship 61725222922517Colman RE, Curtis JR, Nelson JE, Efferen L, Hadjiliadis D, Levine DJ, Meyer KC, Padilla M, Strek M, Varkey B, Singer LGChestBarriers to optimal palliative care of lung transplant candidates. Chest. 2013 Mar; 143(3):736-743.Chest2013-03-01T00:00:002013Barriers to optimal palliative care of lung transplant candidates.23460159Vij R, Strek MEChestDiagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest. 2013 Mar; 143(3):814-824.Chest2013-03-01T00:00:002013Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.Authorship 95988227729262Adegunsoye A, Strek ME, Garrity E, Guzy R, Bag RChestComprehensive Care of the Lung Transplant Patient. Chest. 2017 07; 152(1):150-164.Chest2016-10-08T00:00:002016Comprehensive Care of the Lung Transplant Patient.Authorship 9737512Authorship 97681827888985Oldham JM, Lee C, Valenzi E, Witt LJ, Adegunsoye A, Hsu S, Chen L, Montner S, Chung JH, Noth I, Vij R, Strek MERespiratory medicineAzathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease. Respir Med. 2016 12; 121:117-122.Respir Med2016-11-04T00:00:002016Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.27933058Adegunsoye A, Hrusch CL, Bonham CA, Jaffery MR, Blaine KM, Sullivan M, Churpek MM, Strek ME, Noth I, Sperling AIFrontiers in immunologySkewed Lung CCR4 to CCR6 CD4+ T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function. Front Immunol. 2016; 7:516.Front Immunol2016-11-23T00:00:002016Skewed Lung CCR4 to CCR6 CD4+ T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function.Authorship 97965227521738Adegunsoye A, Strek MEChestTherapeutic Approach to Adult Fibrotic Lung Diseases. Chest. 2016 Dec; 150(6):1371-1386.Chest2016-08-10T00:00:002016Therapeutic Approach to Adult Fibrotic Lung Diseases.Authorship 99582328137497Ahmad K, Barba T, Gamondes D, Ginoux M, Khouatra C, Spagnolo P, Strek M, Thivolet-Béjui F, Traclet J, Cottin VRespiratory medicineInterstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med. 2017 02; 123:56-62.Respir Med2016-10-31T00:00:002016Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients.